22.626 articles found

Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease.

Liu G, Men P, Perry G, Smith MA.

J Nanoneurosci · 2009-06-01

DOI: 10.1166/jns.2009.005PMID: 19936278

mGluR4-positive allosteric modulation as potential treatment for Parkinson's disease.

Hopkins CR, Lindsley CW, Niswender CM.

Future Med Chem · 2009-06-01

DOI: 10.4155/fmc.09.38PMID: 20161443

[11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?

Bartels AL, Willemsen AT, Doorduin J, de Vries EF, Dierckx RA, Leenders KL.

Parkinsonism Relat Disord · 2009-05-31

DOI: 10.1016/j.parkreldis.2009.05.005PMID: 19487152

Nanotechnological applications for the treatment of neurodegenerative disorders.

Modi G, Pillay V, Choonara YE, Ndesendo VM, du Toit LC, Naidoo D.

Prog Neurobiol · 2009-05-30

DOI: 10.1016/j.pneurobio.2009.05.002PMID: 19486920

Wilson's disease: two treatment modalities. Correlations to pretreatment and posttreatment brain MRI.

da Costa Mdo D, Spitz M, Bacheschi LA, Leite CC, Lucato LT, Barbosa ER.

Neuroradiology · 2009-05-29

DOI: 10.1007/s00234-009-0536-5PMID: 19479249

Noradrenergic modulation of the motor response induced by long-term levodopa administration in Parkinsonian rats.

Pérez V, Sosti V, Rubio A, Barbanoj M, Gich I, Rodríguez-Alvarez J, Kulisevsky J.

J Neural Transm (Vienna) · 2009-05-26

DOI: 10.1007/s00702-009-0242-9PMID: 19468817

Autologous neural stem cell transplantation: a new treatment option for Parkinson's disease?

Arias-Carrión O, Yuan TF.

Med Hypotheses · 2009-05-24

DOI: 10.1016/j.mehy.2009.04.029PMID: 19467573

VIRAL NUCLEIC ACID FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

SINCLAIR JOHN, REEVES MATTHEW.

· 2009-05-22

VIRAL NUCLEIC ACID FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

SINCLAIR JOHN, REEVES MATTHEW.

· 2009-05-22

ENDOXIFEN METHODS AND COMPOSITIONS IN THE TREATMENT OF PSYCHIATRIC AND NEURODEGENERATIVE DISEASES

AHMAD ATEEQ, ALI SHOUKATH M, AHMAD MOGHIS U, SHEIKH SAIFUDDIN, AHMAD IMRAN.

· 2009-05-21

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease

LARSEN DAVID S, SANDERS VIRGINIA J, COFFEN DAVID L, LORIMER STEPHEN D, SNOW ALAN D, WEAVERS REX T, NGUYEN BETH P, CASTILLO GERARDO M, LAKE THOMAS P, LARSEN LESLEY.

· 2009-05-21

Comounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, and Parkinson's disease

COFFEN DAVID L, SNOW ALAN D, LAKE THOMAS P, SANDERS VIRGINIA J, LORIMER STEPHEN D, LARSEN DAVID S, WEAVERS REX T, LARSEN LESLEY, CASTILLO GERARDO M, NGUYEN BETH P.

· 2009-05-21